Stemtech Corp.Stemtech Corp.Stemtech Corp.

Stemtech Corp.

No trades
See on Supercharts
Market capitalization
‪5.96 M‬USD
‪53.87 M‬
Beta (1Y)
2.37

About Stemtech Corp.

CEO
Charles S. Arnold
Headquarters
Miramar
Founded
2005
FIGI
BBG001ZZV5V1
Stemtech Corp. engages in the development of nutritional supplements. Its product enhances and supports the work of the body's stem cells by releasing more stem cells, helping to circulate in the blood and migrate it into tissues, where it can perform its daily function of renewal for optimal health. It offers RCM System, stemrelease3, StemFlo, MigraStem, OraStem, OraStem 5-Pack, and D-Fuze. It operates through the following geographical segments: North America, Latin America, and Asia. The company was founded on September 4, 2009 and is headquartered in Miramar, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of STEK is 0.0575 USD — it has increased by 0.88% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Stemtech Corp. stocks are traded under the ticker STEK.
STEK stock is 10.35% volatile and has beta coefficient of 2.37. Check out the list of the most volatile stocks — is Stemtech Corp. there?
Yes, you can track Stemtech Corp. financials in yearly and quarterly reports right on TradingView.
STEK stock has fallen by 17.81% compared to the previous week, the month change is a 33.60% fall, over the last year Stemtech Corp. has showed a 30.30% decrease.
STEK net income for the last quarter is ‪−1.04 M‬ USD, while the quarter before that showed ‪−286.92 K‬ USD of net income which accounts for −263.10% change. Track more Stemtech Corp. financial stats to get the full picture.
Today Stemtech Corp. has the market capitalization of ‪5.96 M‬, it has decreased by 14.18% over the last week.
No, STEK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, STEK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Stemtech Corp. stock right from TradingView charts — choose your broker and connect to your account.
STEK reached its all-time high on Oct 25, 2016 with the price of 33.4000 USD, and its all-time low was 0.0221 USD and was reached on Dec 1, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Stemtech Corp. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Stemtech Corp. stock shows the sell signal. See more of Stemtech Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.